Thymosin Alpha-1

Immune

Synthetic thymic peptide approved in many countries (Zadaxin) for hepatitis and immune modulation.

Your thymus is the gland that trains immune cells — and it shrinks with age, part of why immunity weakens over time. Thymosin Alpha-1 is a synthetic copy of one of its key signalling peptides; it helps T-cells mature and sharpens the immune system's ability to recognise threats. It's an approved drug in dozens of countries (Zadaxin) for hepatitis and as an immune adjunct, and saw heavy use during COVID. Reach for it when you want to genuinely tune up immune function — frequent infections, post-viral recovery, research-stage cancer adjunct — rather than just react to a cold.

Dose
1.6 mg subQ, 2× per week.
Reconstitute
10 mg + 2 mL = 5 mg/mL. 32 units = 1.6 mg.
Schedule
8–12 week cycle. Ongoing for immunocompromised users.
Half-life
~2 hours injected; effects last days.
Timing
AM.
Risks
Mild injection-site reactions. Contraindicated in pregnancy.

within Immune Support